The evaluation of paraoxonase 1 activity in patients with gestational diabetes

Acta Medica Mediterranea

Volumn 29, Issue 4, 2013, Pages 653-657

  Atay, Ahmet Engin ^a   Sakar, Mehmet Nafi ^b   Culcu, Nurdagül Serife Nurani ^c   Simsek, Hakki ^d   Akbas, Halit ^e   Acar, Murat ^f   Isik, Birgul ^c   Tuzcu, Alpaslan Kemal ^c  

^a Bagcilar Education and Research Hospital ^*  (Turkey)

^b Suleymaniye Education and Research Hospital   (Turkey)

^c DICLE UNIVERSITY   (Turkey)

^d YUZUNCU YIL UNIVERSITY   (Turkey)

^e HARRAN UNIVERSITY   (Turkey)

^f Genesis Hospital   (Turkey)

Author keywords

Gestational diabetes; Insulin resistance; Paraoxonase activity

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEMOGRAPHY; ENZYME ACTIVITY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PARITY; PREGNANCY; PREGNANCY DIABETES MELLITUS; WEIGHT GAIN;

EID: 84896700396     PISSN: 03936384     EISSN: 22839720     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hammoud NM, de Valk HW, Biesma DH, Visser G. Gestational diabetes mellitus diagnosed by screening or symptoms: does it matter?. J Matern Fetal Neonatal Med. 2013; 26: 103-5.
2. Katon J, Maynard C, Reiber G. Attempts at Weight Loss in U.S. Women with and without a History of Gestational Diabetes Mellitus. Women's Health Issues. 2012; 22: 447-53.
3. Caudan AEL, Ridaura RL, Villalpando CG, et al. Prediction of Alterations in Glucose Metabolism by Glucose and Insulin Measurements in Early Pregnancy. Archives of Medical Research. 2011; 42: 70-6.
4. Seghieri G, Breschi MC, Anichini R et al. Homocysteine Levels Are Increased in Women With Gestational Diabetes Mellitus. Metab. 2003; 52: 720-3.
5. Moleda P, Homa K, Safranow K, Celewicz Z, Fronczyk A, Majkowska L. Women with normal glucose tolerance and a history of gestational diabetes show significant impairment of β-cell function at normal insulin sensitivity. Diabetes Metab. 2013; 39: 155-62.
6. Krzystek-Korpacka M, Boehm D, Matusiewicz M, Diakowska D, Grabowski K, Gamian A. Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromes-Connection with inflammation. Clinical Biochemistry. 2008; 41: 804-11.
7. Mohamadin A.M., Habib F.A., Elahi T.F. Serum paraoxonase 1 activity and oxidant/antioxidant status in Saudi women with polycystic ovary syndrome. Pathophysiology. 2010; 17: 189-96.
8. Aviram M, Rosenblat M. Paraoxonase and cardiovascular diseases: pharmacological and nutritional influences. Curr Opin Lipidol 2005;16: 393-9.
9. Mackness B, Marsillach J, Elkeles RS et al. Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: results from the PREDICT study. Dis Markers. 2012; 33: 101-12.
10. Ozuguz U, Isik S, Berker D et al. Gestational diabetes and subclinical inflammation: Evaluation of first year postpartum outcomes. Diab Res Clin Prac. 2011; 94: 426-33.
11. Furlong CE, Richter RJ, Seidel SL, Costa LG, Motulsky AG. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem. 1989; 180: 242-7.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-9.
13. Buchanan TA, Xiang AH, Kjos SL et al. Gestational Diabetes: Antepartum Characteristics that Predict Postpartum Glucose Intolerance and Type 2 Diabetes in Latino Women. Diabetes. 1998; 47: 1302-10.
14. Pallordo F, Herranz L, Garcia-Ingelmo T et al. Early Postpartum Metabolic Assessment in Women with Prior Gestational Diabetes. Diabetes Care. 1999; 22: 1053-5.
15. Buchanan TA, Xiang AH, Kjos SL, Trigo E, Lee WP, Peters RK. Antepartum Predictors of the Development of Type 2 Diabetes in Latino Women 11-26 Months After Pregnancies Complicated by Gestational Diabetes. Diab. 1999; 48: 2430-6.
16. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet. Med. 2004; 21: 103-3.
17. Lillioja S, Mott DM, Spraul M et al. Insulin resistance and insulin secretory dysfunction as precursors of noninsulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 1988-92.
18. Karacay O, Sepici-Dincel A, Karcaaltincaba D et al. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation. Diab Res Clin Prac. 2010; 89: 231-8.
19. Suzuki H, Nishizawa T, Tsugawa H, Mogami S, Hibi T. Roles of Oxidative Stress in Stomach Disorders. J. Clin. Biochem. Nutr. 2012; 50: 35-9.
20. MacNeill S, Dodds L, Hamilton DC, Armson BA, Van den Hof M. Rates and risk factors for recurrence of gestational diabetes. Diabetes Care. 2001; 24: 659-62.
21. Buchanan TA, Xiang AH, Kjos S et al. Gestational Diabetes: Antepartum Characteristics that Predict Postpartum Glucose Intolerance and Type 2 Diabetes in Latino Women. Diabetes. 1998; 47: 1302-10.
22. Ouyang F, Shen F, Jiang F, Hu H, Pan M. Risk factors in women with gestational diabetes mellitus. Zhonghua Yu Fang Yi Xue Za Zhi. 2002; 36: 378-81.
23. Cypryk K, Pertynska-Marczewska M, Szymczak W, Zawodniak-Szalapska M, Wilczynski J, Lewinski A. Overweight and obesity as common risk factors for gestational diabetes mellitus (GDM), perinatal macrosomy in offspring and type-2 diabetes in mothers. Przegl Lek. 2005; 62: 38-41.
24. Tran B, Oliver S, Rosa J, Galassetti P. Aspects of inflammation and oxidative stress in pediatric obesity and type 1 diabetes: an overview of ten years of studies. Exp Diabetes Res. 2012; 2012: 683680.
25. Lins TC, Pires AS, Paula RS et al. Association of serum lipid components and obesity with genetic ancestry in an admixed population of elderly women. Genet Mol Biol. 2012; 35: 575-82.
26. Te Morenga L, Mann J. The role of high-protein diets in body weight management and health. Br J Nutr. 2012; 108: 130-8.
27. Solomon CG, Carroll JS, Okamura K, Graves SW, Seely EW. Higher cholesterol and insulin levels in pregnancy are associated with increased risk for pregnancyinduced hypertension. Am J Hypertens. 1999; 12: 276-82.
28. Zavaroni I, Ardigo D, Zuccarelli A et al. Insulin resistance/ compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension. Nutrition, Metabolism & Cardiovascular Diseases. 2006; 16: 22-7.
29. Soran H, Younis NN, Charlton-Menys V, Durrington P. Variation in paraoxonase-1 activity and atherosclerosis, Curr. Opin. Lipidol. 2009; 20: 265-74.
30. Demir B, Demir S, Atamer Y et al. Serum Levels of Lipids, Lipoproteins and Paraoxonase Activity in Preeclampsia. J Int Med Res. 2011; 39: 1427-31.
31. Boa S, Valpreda S, Menato G, et al. Should we consider gestational diabetes a vascular risk factor?. Atherosclerosis. 2007; 194: 72-9.
32. Li C, Gu Q, Protective effect of paraoxonase 1 of highdensity lipoprotein in type 2 diabetic patients with nephropathy. Nephrology (Carlton): 2009; 5: 514-20.